(2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. Bmc Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
. P. Donnan
First name
P.
Middle name
T.
Last name
Donnan
(2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2
. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
. (2013). Impact of clinical trial findings on Bell\textquoterights palsy management in general practice in the UK 2001-2012: interrupted time series regression analysis. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003121
. (2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006
. (2017). Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. http://doi.org/10.1186/s12916-017-0781-0
. (2021). Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2021.04.055
. (2021). Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(21)00088-x
.